Heron Therapeutics Cash Flow Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Year	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013 - 1994
Net Income	-110.56	-182.02	-220.68	-227.28	-204.75	-178.84	-197.48	-173.14	-97.59	-76.37	Upgrade
Depreciation & Amortization	2.9	2.89	3.02	2.85	2.04	1.51	1.53	1.1	0.73	0.58	Upgrade
Share-Based Compensation	32.85	42.98	46.85	50.22	51.41	33.37	30.54	25.96	14.36	8.07	Upgrade
Other Operating Activities	16.02	-10.76	-32.54	-10.61	26.71	-47.85	-4.89	11.99	3.97	7.44	Upgrade
Operating Cash Flow	-58.79	-146.91	-203.35	-184.82	-124.58	-191.81	-170.3	-134.1	-78.53	-60.28	Upgrade
Capital Expenditures	-1.53	-1.6	-2.99	-6.81	-7.15	-9.15	-2.48	-3.14	-0.85	-1.44	Upgrade
Change in Investments	19.53	-1.73	35.72	215.77	-14.63	-269.4	10.21	18.01	-56.12	0	Upgrade
Investing Cash Flow	18	-3.32	32.73	208.96	-21.78	-278.55	7.74	14.88	-56.96	-1.44	Upgrade
Share Issuance / Repurchase	29.76	75.06	7.07	9.08	186.43	382.61	318.73	7.46	137.99	62.11	Upgrade
Debt Issued / Paid	24.35	0	148.96	0.03	0	-25	-25	50	0	0	Upgrade
Financing Cash Flow	54.11	75.06	156.03	9.11	186.43	357.61	293.73	57.46	137.99	62.11	Upgrade
Net Cash Flow	13.31	-75.18	-14.6	33.24	40.06	-112.75	131.17	-61.77	2.51	0.39	Upgrade
Free Cash Flow	-60.32	-148.51	-206.34	-191.63	-131.73	-200.95	-172.78	-137.23	-79.37	-61.72	Upgrade
Free Cash Flow Margin	-47.48%	-137.93%	-238.97%	-216.20%	-90.25%	-259.38%	-561.56%	-10729.63%	-	-	Upgrade
Free Cash Flow Per Share	-0.44	-1.36	-2.10	-2.11	-1.61	-2.75	-3.20	-3.62	-2.40	-2.32	Upgrade

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).